HIV 101 | April 20, 2023
Date of Presentation: April 20, 2023
In this series of presentations, Dr. Jorge Mera, ECHO Medical Director, provides a clinical update on emerging COVID-19 topics. Then, Dr. Jonathan Iralu, Chief Clinical Consultant for Infectious Diseases at IHS, presents on HIV (human immunodeficiency virus) in primary care.
Recording:
Presented by:
Dr. Jonathan Iralu, MD, FACP, FISDA | Dr. Jorge Mera, MD, FACP
Dr. Jonathan Iralu, MD, FACP, FISDA, is the Indian Health Service Chief Clinical Consultant for Infectious Diseases. He has a special interest in HIV, tuberculosis, and sexually transmitted disease care in rural communities. His research has focused on undifferentiated febrile illness in the American Southwest and on rural HIV care delivery. He has worked at Gallup Indian Medical Center since 1994 and is an instructor at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital Division of Global Health Equity in Boston, Massachusetts.
Dr. Jorge Mera, MD, FACP, is the Director of Infectious Diseases for Cherokee Nation Health Services (CNHS), the largest tribally operated health care system in the United States. He completed his fellowship in Infectious Diseases and Clinical Microbiology at Baylor College of Medicine in Houston, Texas and is Board Certified by the American Board of Internal Medicine (ABIM) in Infectious Diseases. During recent years Jorge’s efforts have been dedicated to organizing the Cherokee Nation HCV elimination program, as well as the HIV/HCV ECHO project. He is also the Director of the HIV clinic since 2012 and the Principal Investigator of the End the HIV Epidemic for the CNHS. He is a Clinical Assistant Professor in the Department of Internal Medicine of the Oklahoma State University Health Science Center and a Fellow of the American College of Physicians.
Resources Provided:
- To Claim CE
- Register for the HIV and PrEP Virtual Training
- HIV Primary Care Treatment Guidelines for Adults and Adolescents (IHS)
- Limited Supply of Benzathine penicillin G (Bicillin® L-A) for treatment of Syphilis (NPTC)
Date added: April 16, 2023